Background Image
Table of Contents Table of Contents
Previous Page  361 / 658 Next Page
Information
Show Menu
Previous Page 361 / 658 Next Page
Page Background

Screening Drugs and Toxic Compounds with

LC-MS/MS: An Alternative to LC-UV for

Research Toxicology Labs

Jordan Velardo

1

, Monique Manchon

1

, Bénédicte Duretz

2

, Dennis Nagtalon

3

, Marta Kozak

3

;

1

Laboratory of Toxicology, Lyon Sud Hospital, Pierre-Bénite, France;

2

Thermo Fisher Scientific, Les Ulis, France;

3

Thermo Fisher

Scientific, San Jose, CA, USA

Introduction

Screening for drugs of abuse and other toxic compounds

in biological samples has quickly become a routine assay

conducted in many research toxicology laboratories. The

main challenge is to get rapid and accurate results amidst

the generally large number of potential analytes to be

identified within complex biological matrices. One of the

techniques widely used in this area is high pressure liquid

chromatography (HPLC) combined with photo diode

array detection (DAD) or ultra-violet (UV) detection. The

most popular LC-UV platform has been the Bio-Rad

®

REMEDi

HS drug profiling system. When this platform

was recently discontinued, a significant technological gap

became apparent. Now this gap is rapidly being filled by

newer, more effective high pressure liquid chromatography

- mass spectrometry (HPLC-MS) technologies.

Here we present the workflow

and results obtained by using the

Thermo Scientific ToxSpec Analyzer,

a new UHPLC-MS system based on

ultra-high pressure liquid

chromatography and linear ion trap

mass spectrometry technology.

Goal

Evaluate an LC-MS/MS method for

screening and semi-quantitation of

drugs and toxic compounds in serum

and urine matrices to determine if

this approach can provide an

alternative to REMEDi technology

for research toxicology.

Experimental

The ToxSpec

Analyzer combines

hardware, software, and screening

methodologies designed to

significantly simplify and improve the

screening assay workflow. LC-MS

2

data is acquired by using a pre-

configured instrument method, and the data is

automatically processed, post-acquisition, by Thermo

Scientific ToxID automated drug screening software.

The LC-MS screening was performed on Thermo

Scientific instrumentation including an LXQ

linear ion

trap mass spectrometer coupled to an Accela

UHPLC

system using a polarity-switching and scan-dependent

MS/MS experiment (Figure 1). The MS

2

spectra generated

were processed through ToxID

software. Using a novel

screening algorithm, the software program identifies target

analytes through a MS

2

library search against a large

spectral library of known analytes as well as expected

retention times. Semi-quantitative data results can also be

generated concurrently from the MS

2

spectral intensity

ratios between the target analyte and the corresponding

internal standard.

Key Words

• ToxSpec

Analyzer

• ToxID software

• LXQ Linear Ion

Trap

• Accela UHPLC

System

Application

Note: 467

Figure 1: Polarity-switching and scan-dependent

MS/MS experiment

DOWNLOAD